NIH to evaluate remdesivir treatment for COVID during pregnancy
Por um escritor misterioso
Descrição
WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]
Investigational Antivirals for Managing COVID-19
Evaluation & Management of COVID-19 in Pregnancy
Infectious Disease Reports, Free Full-Text
Global interim guidance on coronavirus disease 2019 (COVID‐19
Mild or Moderate Covid-19
13 Things To Know About Paxlovid, the Latest COVID-19 Pill > News
New Perspectives on Antimicrobial Agents: Remdesivir Treatment for
COVID-19 and Pregnancy: Risks and Outcomes - Nursing for Women's
Hydroxychloroquine with or without azithromycin for treatment of
Facebook Post Misleads on NIH's Position on Ivermectin
Messages from the COVID-19 Response Task Force
Remdesivir for the treatment of hospitalized patients with severe
Critical study of Gilead drug shows coronavirus patients
Coronavirus Drug and Treatment Tracker - The New York Times
Therapeutic Management of Nonhospitalized Adults With COVID-19
de
por adulto (o preço varia de acordo com o tamanho do grupo)
